LINZESS® (linaclotide) is indicated for the treatment of both irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults and functional constipation (FC) in pediatric patients 6 to 17 years of age.1

Her IBS-C is more than constipation

Choose LINZESS to help relieve constipation and overall abdominal symptoms (bloating, pain, and discomfort).1

Why wait?

Not an actual patient.

Patient with IBS-C